GLP-1 Receptor Agonists: A Cardiology Perspective

<p>Credits: 0.25 <span class="AMA1"><em>AMA PRA Category 1 Credits</em>™, 0.25 ABIM MOC</span> or 0.25 <span class= "AANP">AANP, including 0.25 AANP Pharm</span></p> <p>Claim CME/CE credit: <span style="font-size: 12pt;"><a href= "https://www.pri-med.com/online-education/podcast/novo-glp1-podcast-1"> https://www.pri-med.com/online-education/podcast/novo-glp1-podcast-1</a></span></p> <p>Overview: In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. He will present the recent American College of Cardiology guidelines and discuss the perspective of a cardiologist on these agents with emerging significance in cardiovascular risk reduction.</p> <p>Guest: Ty J. Gluckman, MD, FACC, FAHA</p>